Circ-ELP3 was upregulated in breast cancer patients (p-value = 0.004). On the other hand, serum Circ-FAF1 was seen to be decreased in breast cancer patients than controls (p-value = 0.001).
Serum Circ-FAF1/Circ-ELP3: A novel potential biomarker for breast cancer diagnosis.